Side-by-side comparison of AI visibility scores, market position, and capabilities
Mexico City shared equity homeownership platform partnering with HSBC and Citibanamex for non-debt housing access; YC W23 $500K targeting 9M+ housing unit gap with $1M revenue competing with Infonavit for Mexican homebuyer financing.
Holacasa is a Mexico City-based home equity financing platform — backed by Y Combinator (W23) with $500,000 raised from YC, Goodwater Capital, Invariantes Fund, 1517 Fund, and Accel — providing Mexican homebuyers with shared equity financing that enables access to non-debt homeownership without the credit score, down payment, and debt-to-income ratio requirements that exclude the majority of Mexican families from traditional mortgage programs, generating $1 million in revenue in 2024 with a 9-person team through partnerships with 10+ major Mexican banks including HSBC, Citibanamex, and Banorte. Founded in 2022, Holacasa targets the Mexican housing affordability crisis where 9+ million housing units are needed but 70%+ of the population lacks access to formal mortgage credit.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.